Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» asundexian
asundexian
Bayer's trial flop, courtroom setback could restrict CEO's options amid strategic review: analyst
Bayer's trial flop, courtroom setback could restrict CEO's options amid strategic review: analyst
Fierce Pharma
Bayer
Pharma CEOs
Bill Anderson
asundexian
Flag link:
Bayer's blood thinner fails Eliquis test, sinking phase 3 trial and denting $5B sales forecast
Bayer's blood thinner fails Eliquis test, sinking phase 3 trial and denting $5B sales forecast
Fierce Biotech
Bayer
asundexian
bloodthinners
Eliquis
clinical trials
Flag link:
Bayer doubles down on Factor XIa with new phase 3 trial
Bayer doubles down on Factor XIa with new phase 3 trial
Pharmaphorum
Bayer
clinical trials
asundexian
Factor Xa inhibition
atrial fibrillation
Flag link:
Bayer begins key tests for closely watched blood thinner
Bayer begins key tests for closely watched blood thinner
BioPharma Dive
Bayer
clinical trials
bloodthinners
asundexian
Flag link:
Running behind Bristol Myers and J&J, Bayer inches forward in the next-gen blood thinner race
Running behind Bristol Myers and J&J, Bayer inches forward in the next-gen blood thinner race
Endpoints
Bayer
bloodthinners
asundexian
clinical trials
Eliquis
Bristol Myers Squibb
JNJ
Flag link:
